Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport as an Adjunctive Treatment to Bracing in Adolescent Idiopathic Scoliosis
NCT03935295Phase 4Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2020
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in adolescent idiopathic scoliosis (AIS), sponsored by Johns Hopkins University. Started Sep 2020; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on NCT03935295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03935295.